SRT-2104
id:
srt-2104-318-5266570
title:
SRT-2104
text:
SRT-2104 is an experimental drug that was studied by Sirtris Pharmaceuticals as a small-molecule activator of the sirtuin subtype SIRT1. The compound progressed to Phase II human trials for Type II diabetes before development was discontinued, however it continues to be widely used in animal research into the functions of SIRT1.
brand slug:
wiki
category slug:
encyclopedia
description:
Organic compound, experimental pharmaceuticum
original url:
https://en.wikipedia.org/wiki/SRT-2104
date created:
date modified:
2023-07-10T13:20:12Z
main entity:
{"identifier":"Q27258795","url":"https://www.wikidata.org/entity/Q27258795"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/09/SRT2104_structure.png","width":723,"height":890}
fields total:
13
integrity:
15